Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,936 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

NCT02028884

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Hopital de Hautepierre CHRU de Strasbourg Strasbourg, France
  • NeuroCure Clinical Research Center (NCRC) Berlin, Germany
  • St. Josef-Hospital, Klinik für Neurologie Bochum, Germany
View all 40 locations
View Trial Details
Completed

MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study

NCT05058729

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Research Site Baltimore, Maryland, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Las Vegas, Nevada, United States
  • Research Site New York, United States
View Trial Details

Related conditions